Effects of sodium glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on blood urea level
Effects of sodium glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on blood urea level
ISSN: 2757-976X ;
E-ISSN: 2757-976X ;
- Year : 2023
- Vol : 3
- No : 3
- Page : 102-108
ÖZ
Aim: Glucagon is known that its secretion increases with the use of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and decreases with the use of dipeptidyl peptidase-4 inhibitor (DPP-4i). Considering the different effects on glucagon, in this study, it was aimed to evaluate the blood urea levels and estimated glomerular filtration rate in patients using these two groups of drugs together.
Methods: 220 patients, 109 in the SGLT2i group and 111 in the DPP4i group, were included in the study. Patients before the start of treatment, after treatment 1-3. month and 4-6. month after treatment blood tests were evaluated retrospectively.
Results: In the SGLT2i group, there was a statistically significant difference in blood urea level, creatinine and estimated glomerular filtration rate between visits 0, 1 and 2. In the DPP-4i group, there was no statistically significant difference in blood urea level and estimated glomerular filtration rate between visits 0, 1 and 2.
Conclusion: It was found that blood urea level increased in patients using SGLT2i, while it did not change in patients using DPP-4i. There is a need for prospective studies that evaluate these drugs as both monotherapy and combination therapy, and also evaluate the interaction of plasma glucagon levels with urea in those using this drug.
Methods: 220 patients, 109 in the SGLT2i group and 111 in the DPP4i group, were included in the study. Patients before the start of treatment, after treatment 1-3. month and 4-6. month after treatment blood tests were evaluated retrospectively.
Results: In the SGLT2i group, there was a statistically significant difference in blood urea level, creatinine and estimated glomerular filtration rate between visits 0, 1 and 2. In the DPP-4i group, there was no statistically significant difference in blood urea level and estimated glomerular filtration rate between visits 0, 1 and 2.
Conclusion: It was found that blood urea level increased in patients using SGLT2i, while it did not change in patients using DPP-4i. There is a need for prospective studies that evaluate these drugs as both monotherapy and combination therapy, and also evaluate the interaction of plasma glucagon levels with urea in those using this drug.
Correspondence Address :
Email : [email protected]
Cite this Article As : Çelik Y, Dağdeviren M, Ertuğrul DT, Beyan E. Sodyum Glukoz Ko-Transporter 2 İnhibitörü ve Dipeptidil Peptidaz-4 İnhibitörü İlaçların Kan Üre Düzeyi Üzerine Etkileri. Mev Med Sci. 2023;3(3):102-108
Description : Yazarların hiçbiri, bu makalede bahsedilen herhangi bir ürün, aygıt veya ilaç ile ilgili maddi çıkar ilişkisine sahip değildir. Araştırma, herhangi bir dış organizasyon tarafından desteklenmedi.Yazarlar çalışmanın birincil verilerine tam erişim izni vermek ve derginin talep ettiği takdirde verileri incelemesine izin vermeyi kabul etmektedirler. None of the authors, any product mentioned in this article, does not have a material interest in the device or drug. Research, not supported by any external organization. grant full access to the primary data and, if requested by the magazine they agree to allow the examination of data.
Email : [email protected]
Cite this Article As : Çelik Y, Dağdeviren M, Ertuğrul DT, Beyan E. Sodyum Glukoz Ko-Transporter 2 İnhibitörü ve Dipeptidil Peptidaz-4 İnhibitörü İlaçların Kan Üre Düzeyi Üzerine Etkileri. Mev Med Sci. 2023;3(3):102-108
Description : Yazarların hiçbiri, bu makalede bahsedilen herhangi bir ürün, aygıt veya ilaç ile ilgili maddi çıkar ilişkisine sahip değildir. Araştırma, herhangi bir dış organizasyon tarafından desteklenmedi.Yazarlar çalışmanın birincil verilerine tam erişim izni vermek ve derginin talep ettiği takdirde verileri incelemesine izin vermeyi kabul etmektedirler. None of the authors, any product mentioned in this article, does not have a material interest in the device or drug. Research, not supported by any external organization. grant full access to the primary data and, if requested by the magazine they agree to allow the examination of data.
Effects of sodium glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on blood urea level, Araştırma Makalesi,
2023, Vol. 3 (3)
2023, Vol. 3 (3)
Received :16.02.2023,
Accepted : 04.11.2023,
Published Online : 12.12.2023
Mevlana Medical Sciences Journal
ISSN: 2757-976X ;
E-ISSN: 2757-976X ;
Keywords